Keraring Implantation Based on Alfonso Nomogram

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Mar 1, 2026 to Sep 1, 2026 Show 4 more changesShow less
    • Start date: Mar 1, 2025 to Sep 1, 2025
    • Trial completed
    • Eligibility criteria expanded, about 8 words
    • Publications: details revised at 1 of 1 entry
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Assiut University
1,667 trials monitored
See 15 trials at risk
Keratoconus (KC) is a bilateral asymmetric progressive corneal degenerative disease associated with corneal thinning and protrusion. The management of moderate progressive keratoconus involves halting its progression through corneal cross-linking as well as flattening of the ectatic steep cornea through the implantation of intrastromal corneal rings (ICR). Different nomograms were used to guide ophthalmic surgeons for the proper choice of ICR implantation to achieve the best results. The aim of the current study is to assess the visual, refractive and tomographic outcomes of Keraring implantation based on the Alfonso nomogram, in patients with keratoconus.
Trial Details
NCT Number NCT07540208
Lead Sponsor Assiut University
Conditions
(from sponsor)		 Keratoconic Subjects
Related terms Keratoconus
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov